Target intelligence / Profile preview

GPN-loop GTPase 2 (GPN2)

Target
GPN2
Molecular classification
Enzyme, GTPase, SIMIBI class GTPase, Assembly chaperone (for protein complexes)
01

Overview

**GPN-loop GTPase 2 (GPN2)** is a member of the evolutionarily conserved GPN-loop GTPase enzyme family, defined by a unique Gly-Pro-Asn (GPN) motif in the G-domain, typically involved in GTP binding and hydrolysis. In humans, there are three paralogs: GPN1, GPN2, and GPN3. GPN2 functions as an essential assembly chaperone for the biogenesis of the 12-subunit RNA polymerase II (Pol II) complex, preventing misassembly or aggregation by binding and releasing hydrophobic peptide regions in subunits through a GTP-dependent mechanism involving large conformational changes. It forms part of a broader family (SIMIBI class) of GTPases that typically assemble as homo- or heterodimers and operate via a "lock-switch-rock" mechanism to facilitate complex allosteric assembly processes. Loss-of-function of GPN2 in yeast is lethal, underlining its essential cellular role. There are currently no known direct pharmacologic agents, disease associations, or clinical biomarkers based on available data[1][2]. **Notes:** - GPN2 is NOT considered a direct therapeutic target or receptor but rather an essential enzyme for assembly of critical cellular complexes[1][2]. - There are no current drugs, biomarkers, or safety concerns associated with GPN2 based on present knowledge. - No evidence of incorrect assignment, spelling, or concept.

Other names
GPN2ATPBD1BATP-binding domain 1 family member BUNQ5828/PRO19647FLJ10349
02

Biological functions

Biogenesis and assembly of RNA polymerase II complexChaperone-like prevention of misassembly and aggregation of protein complexesMaintenance of proper cellular localization of protein subunits (especially RNA polymerase II)Potential involvement in other macromolecular complex assembly
03

Disease associations

Other (essential for cell viability; indirect connection with diseases related to defects in assembly of RNA polymerase II or certain myopathies)

Beyond the preview

Go deeper on GPN-loop GTPase 2 (GPN2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GPN-loop GTPase 2 (GPN2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call